These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1651161)

  • 81. Diabetes mellitus, dyslipoproteinaemias and atherosclerosis.
    Steiner G
    Diabetologia; 1997 Jul; 40 Suppl 2():S147-8. PubMed ID: 9248725
    [No Abstract]   [Full Text] [Related]  

  • 82. Xanthomas and the inherited hyperlipoproteinemias in children and adolescents.
    Maher-Wiese VL; Marmer EL; Grant-Kels JM
    Pediatr Dermatol; 1990 Sep; 7(3):166-73. PubMed ID: 2123340
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Gene-environment interactions in atherosclerosis.
    Hegele RA
    Mol Cell Biochem; 1992 Aug; 113(2):177-86. PubMed ID: 1325605
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The 15th annual meeting of the European Lipoprotein Club.
    Aggerbeck LP; Angelin B; Armstrong V; Franceschini G; Humphries S; Rosseneu M; Soutar A; Zechner R
    Arterioscler Thromb; 1993 Apr; 13(4):618-27. PubMed ID: 8385481
    [No Abstract]   [Full Text] [Related]  

  • 85. Application of immunological techniques to the investigation of atherogenesis.
    Walton KW
    Adv Exp Med Biol; 1978; 109():145-54. PubMed ID: 364944
    [No Abstract]   [Full Text] [Related]  

  • 86. Current understanding of the mechanisms of atherogenesis.
    Kottke BA
    Am J Cardiol; 1993 Sep; 72(8):48C-53C; discussion 53C-54C. PubMed ID: 8372801
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
    Esse R; Barroso M; Tavares de Almeida I; Castro R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781581
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease.
    Chrisp P; Lewis NJ; Milne RJ
    Pharmacoeconomics; 1992 Feb; 1(2):124-45. PubMed ID: 10146941
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lp(a): a link between thrombosis and atherosclerosis.
    Scanu AM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():76-8. PubMed ID: 1387094
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Lipoprotein metabolism and atherogenesis: implications for therapy.
    Kostner GM
    Cardiology; 1991; 78(3):194-201. PubMed ID: 1651161
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.